Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B
dc.contributor.author | Evon, Donna M. | |
dc.contributor.author | Lin, Hsing‐hua S. | |
dc.contributor.author | Fontana, Robert J. | |
dc.contributor.author | Khalili, Mandana | |
dc.contributor.author | Yim, Colina | |
dc.contributor.author | Wahed, Abdus S. | |
dc.contributor.author | Hoofnagle, Jay H. | |
dc.contributor.author | Lau, Daryl T.‐y. | |
dc.date.accessioned | 2021-06-02T21:09:43Z | |
dc.date.available | 2022-06-02 17:09:42 | en |
dc.date.available | 2021-06-02T21:09:43Z | |
dc.date.issued | 2021-05 | |
dc.identifier.citation | Evon, Donna M.; Lin, Hsing‐hua S. ; Fontana, Robert J.; Khalili, Mandana; Yim, Colina; Wahed, Abdus S.; Hoofnagle, Jay H.; Lau, Daryl T.‐y. (2021). "Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B." GastroHep (3): 196-208. | |
dc.identifier.issn | 1478-1239 | |
dc.identifier.issn | 1478-1239 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/167840 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | Springer New York | |
dc.title | Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Gastroenterology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/167840/1/ygh2458.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/167840/2/ygh2458_am.pdf | |
dc.identifier.doi | 10.1002/ygh2.458 | |
dc.identifier.source | GastroHep | |
dc.identifier.citedreference | Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. Germany: Springer New York; 2009. | |
dc.identifier.citedreference | Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018; 67: 1560 - 1599. | |
dc.identifier.citedreference | Saffari M, Alavian SM, Naderi MK, Pakpour AH, Al Zaben F, Koenig HG. Cross- cultural adaptation and psychometric assessment of the Liver Disease Symptom Index 2.0 to measure health- related quality of life among Iranian patients with chronic hepatitis B. J Transcult Nurs. 2016; 27: 496 - 508. | |
dc.identifier.citedreference | Jang Y, Boo S, Yoo H. Hepatitis B virus infection: fatigue- associated illness experiences among Koreans. Gastroenterol Nurs. 2018; 41: 388 - 395. | |
dc.identifier.citedreference | Simonetti G, Gitto S, Golfieri L, et al. Quality of life of hepatitis B virus surface antigen- positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog- treated patients. Eur J Gastroenterol Hepatol. 2018; 30: 14 - 20. | |
dc.identifier.citedreference | Evon DM, Wahed AS, Johnson G, et al. Fatigue in patients with chronic hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Dig Dis Sci. 2016; 61: 1186 - 1196. | |
dc.identifier.citedreference | Evon DM, Lin H- H, Khalili M, et al. Patient- reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross- sectional analysis. Aliment Pharmacol Ther. 2020; 51: 457 - 468. | |
dc.identifier.citedreference | Ghany MG, Perrillo R, Li R, et al. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015; 13: 183 - 192. | |
dc.identifier.citedreference | Kistler KD, Molleston J, Unalp A, Abrams SH, Behling C, Schwimmer JB. Symptoms and quality of life in obese children and adolescents with non- alcoholic fatty liver disease. Aliment Pharmacol Ther. 2010; 31: 396 - 406. | |
dc.identifier.citedreference | Di Bisceglie AM, Lombardero M, Teckman J, et al. Determination of hepatitis B phenotype using biochemical and serological markers. J Viral Hepat. 2017; 24: 320 - 329. | |
dc.identifier.citedreference | Ruhl CE, Everhart JE. Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology. 2012; 55: 447 - 454. | |
dc.identifier.citedreference | Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002; 137: 1 - 10. | |
dc.identifier.citedreference | Lok AS, Perrillo R, Lalama CM, et al. medLow incidence of adverse outcomes in adults with chronic hepatitis B virus infection in the era of antiviral therapy. Hepatology. 2020. https://doi.org/10.1002/hep.31554 | |
dc.identifier.citedreference | Tu T, Block JM, Wang S, Cohen C, Douglas MW. The lived experience of chronic hepatitis B: a broader view of its impacts and why we need a cure. Viruses. 2020; 12: 515. | |
dc.identifier.citedreference | Mahadeva S, Mahfudz AS, Vijayananthan A. Ethnicity influences pain after ultrasound- guided percutaneous liver biopsy. Eur J Gastroenterol Hepatol. 2015; 27: 1378 - 1381. | |
dc.identifier.citedreference | Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology. 2002; 36: S237 - S244. | |
dc.identifier.citedreference | Marcellin P, Lau GKK, Bonino F, et al. Peginterferon alfa- 2a alone, lamivudine alone, and the two in combination in patients with HBeAg- negative chronic hepatitis B. N Engl J Med. 2004; 351: 1206 - 1217. | |
dc.identifier.citedreference | Cooper CL, Galanakis C, Donelle J, et al. HCV- infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study. BMC Infect Dis. 2019; 19: 712. | |
dc.identifier.citedreference | Yim A, Humphries D, Abuova G. Food, alcohol and cigarette availability and consumption in Almaty, Kazakstan: results and appraisal of a rapid assessment. Public Health Nutr. 2003; 6: 791 - 800. | |
dc.identifier.citedreference | Karacaer Z, Cakir B, Erdem H, et al. Quality of life and related factors among chronic hepatitis B- infected patients: a multi- center study, Turkey. Health Qual Life Outcomes. 2016; 14: 153. | |
dc.identifier.citedreference | Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign- born persons living in the United States by country of origin. Hepatology. 2012; 56: 422 - 433. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.